Bank of Montreal
ARLZ

Bank of Montreal’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Bank of Montreal’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-2,551
Closed -$1K – 5057
2018
Q2 		$1K Sell
2,551
-55,674
-96% -$45.7K ﹤0.01% 4688
2018
Q1 		$87K Buy
58,225
+57,661
+10,224% +$101K ﹤0.01% 3017
2017
Q4 		$1K Sell
564
-73
-11% -$120 ﹤0.01% 4143
2017
Q3 		$1K Hold
637
– – ﹤0.01% 4137
2017
Q2 		$1K Sell
637
-1,994
-76% -$2.88K ﹤0.01% 4123
2017
Q1 		$5K Sell
2,631
-22,141
-89% -$83.2K ﹤0.01% 3720
2016
Q4 		$125K Sell
24,772
-13
-0.1% -$62 ﹤0.01% 2726
2016
Q3 		$120K Sell
24,785
-5,410
-18% -$24.7K ﹤0.01% 2684
2016
Q2 		$100K Sell
30,195
-9,786
-24% -$36.9K ﹤0.01% 2804
2016
Q1 		$142K Buy
+39,981
New +$206K ﹤0.01% 2650

Other funds holding ARLZ

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Bank of Montreal's ARLZ Position: Q3 2018 in Review

Bank of Montreal sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q3 2018, closing a stake of 2,551 shares — an estimated $1K sold.

Bank of Montreal first reported a position in ARLZ in Q1 2016 and held it in 10 quarters. The position peaked at $142K in Q1 2016. 4 funds tracked by Wall St. Rank hold ARLZ as of Q3 2018.

  • Bank of Montreal reported no remaining Aralez Pharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
  • Bank of Montreal sold 2,551 Aralez Pharmaceuticals Inc. shares in Q3 2018, an estimated $1K.
  • Bank of Montreal first reported a position in Aralez Pharmaceuticals Inc. in Q1 2016 and held it in 10 quarters.
  • Bank of Montreal's Aralez Pharmaceuticals Inc. position peaked at $142K in Q1 2016.
  • 4 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q3 2018.

Based on Bank of Montreal's 13F filing for Q3 2018, filed 12 Oct 2018.